275 related articles for article (PubMed ID: 35287684)
1. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
Papazoglou AS; Kartas A; Moysidis DV; Tsagkaris C; Papadakos SP; Bekiaridou A; Samaras A; Karagiannidis E; Papadakis M; Giannakoulas G
Cardiovasc Diabetol; 2022 Mar; 21(1):39. PubMed ID: 35287684
[TBL] [Abstract][Full Text] [Related]
2. Impact of diabetes mellitus and poor glycemic control on the prevalence of left atrial low-voltage areas and rhythm outcome in patients with atrial fibrillation ablation.
Matsuda Y; Masuda M; Uematsu H; Sugino A; Ooka H; Kudo S; Fujii S; Asai M; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Hata Y; Higashino N; Nakao S; Kusuda M; Mano T
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):775-784. PubMed ID: 38375957
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
4. Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population-Based Cohort Study.
Abdel-Qadir H; Gunn M; Lega IC; Pang A; Austin PC; Singh SM; Jackevicius CA; Tu K; Dorian P; Lee DS; Ko DT
J Am Heart Assoc; 2022 Feb; 11(4):e023643. PubMed ID: 35132863
[TBL] [Abstract][Full Text] [Related]
5. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
Fatemi O; Yuriditsky E; Tsioufis C; Tsachris D; Morgan T; Basile J; Bigger T; Cushman W; Goff D; Soliman EZ; Thomas A; Papademetriou V
Am J Cardiol; 2014 Oct; 114(8):1217-22. PubMed ID: 25159234
[TBL] [Abstract][Full Text] [Related]
6. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
Ashburner JM; Go AS; Chang Y; Fang MC; Fredman L; Applebaum KM; Singer DE
J Am Coll Cardiol; 2016 Jan; 67(3):239-47. PubMed ID: 26796386
[TBL] [Abstract][Full Text] [Related]
7. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
[TBL] [Abstract][Full Text] [Related]
8. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65.
Gumprecht J; Lip GYH; Sokal A; Średniawa B; Stokwiszewski J; Zdrojewski T; Rutkowski M; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
Sci Rep; 2023 Oct; 13(1):17252. PubMed ID: 37828071
[TBL] [Abstract][Full Text] [Related]
9. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
[TBL] [Abstract][Full Text] [Related]
10. Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus: a nationwide cohort study.
Lee SR; Ahn HJ; Choi EK; Lee SW; Han KD; Oh S; Lip GYH
Cardiovasc Diabetol; 2023 Jan; 22(1):18. PubMed ID: 36717853
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
[TBL] [Abstract][Full Text] [Related]
12. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
[TBL] [Abstract][Full Text] [Related]
13. Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.
Moss AS; Dimitropoulos G; Connolly DL; Lip GYH
Expert Opin Pharmacother; 2017 Aug; 18(11):1101-1114. PubMed ID: 28669216
[TBL] [Abstract][Full Text] [Related]
14. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study.
Saliba W; Barnett-Griness O; Elias M; Rennert G
Heart Rhythm; 2015 May; 12(5):886-92. PubMed ID: 25614249
[TBL] [Abstract][Full Text] [Related]
15. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
[TBL] [Abstract][Full Text] [Related]
16. Relation of Hemoglobin A1C Levels to Risk of Ischemic Stroke and Mortality in Patients With Diabetes Mellitus and Atrial Fibrillation.
Kezerle L; Haim M; Akriv A; Senderey AB; Bachrach A; Leventer-Roberts M; Tsadok MA
Am J Cardiol; 2022 Jun; 172():48-53. PubMed ID: 35361475
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects.
Johansen OE; Brustad E; Enger S; Tveit A
Cardiovasc Diabetol; 2008 Sep; 7():28. PubMed ID: 18822173
[TBL] [Abstract][Full Text] [Related]
18. Relation of Diabetes Mellitus to Incident Dementia in Patients With Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).
Jiayaspathi A; Chen LY; Selvin E; Gottesman RF; Knopman DS; Mosley TH; Norby FL; Alonso A
Am J Cardiol; 2022 Feb; 165():51-57. PubMed ID: 34887073
[TBL] [Abstract][Full Text] [Related]
19. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
[TBL] [Abstract][Full Text] [Related]
20. Is pre-diabetes a predictor of events in patients with atrial fibrillation?
Ledo Piñeiro A; Abu-Assi E; González Bermúdez I; Noriega Caro V; Íñiguez-Romo A; Raposeiras-Roubín S
Int J Cardiol; 2024 Jul; 407():132086. PubMed ID: 38648915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
